Publications
Detailed Information
Discordant ErbB2 status between primary gastric carcinomas and metastatic/recurrent carcinomas
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, W. | - |
dc.contributor.author | Kim, M. | - |
dc.contributor.author | Lee, B. | - |
dc.date.accessioned | 2012-07-10T00:42:38Z | - |
dc.date.available | 2012-07-10T00:42:38Z | - |
dc.date.issued | 2009-09 | - |
dc.identifier.citation | EJC SUPPLEMENTS; Vol.7(2); 378-378 | ko_KR |
dc.identifier.issn | 1359-6349 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78675 | - |
dc.description.abstract | Background: To evaluate the ErbB2 status in primary gastric carcinoma
(GC) and secondary (metastatic or recurrent) lesions, 614 cases of GC were examined. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | ko_KR |
dc.title | Discordant ErbB2 status between primary gastric carcinomas and metastatic/recurrent carcinomas | ko_KR |
dc.type | Conference Paper | ko_KR |
dc.identifier.doi | 10.1016/S1359-6349(09)71279-0 | - |
dc.citation.journaltitle | EJC SUPPLEMENTS | - |
dc.description.tc | 0 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.